Health Care · Pharmaceutical Preparations · Nasdaq · CIK 1868279 · FYE Dec 31 · Prices AT CLOSE 2026-07-29 (USD) — end-of-day, never a live or intraday quote
Last $30.04Day +0.20%Mkt cap $1.4B1Y +48.4%Off 52W high −16.2%Vol (1Y) 57.3%
Daily closing price, split-adjusted to the current basis; 2.5y shown of 622 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Short interest16.5% of sh out |
| Days to cover17.9d |
| 13F net flow (QoQ)+1.78% |
| Top-10 13F concentration67.0% |
| Next report (est.)2026-08-10 |
Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Earnings (TTM)-$145.2M |
| ROE−58.9% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
| YTD+49.3% |
| 1Y+48.4% |
| Since incept. (ann.)+17.6% |
Total return through 2026-07-29 · series begins 2024-01-26. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)57.3% |
| Ann. volatility (3Y)54.6% |
| Sharpe (1Y)0.93 |
| Sharpe (3Y)0.57 |
| Max drawdown (1Y)−24.2% |
| Max drawdown (3Y)−54.3% |
| Beta (3Y vs SPY)1.38 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| SUVRETTA CAPITAL MANAGEMENT, LLC | 4.4M | $102M | 9.45% | +7.2% |
| INFINITUM ASSET MANAGEMENT, LLC | 4.1M | $96M | 8.91% | +0.6% |
| HHLR ADVISORS, LTD. | 3.9M | $91M | 8.44% | +0.0% |
| ORBIMED ADVISORS LLC | 3.0M | $70M | 6.50% | +0.0% |
| FMR LLC | 3.0M | $70M | 6.48% | −18.6% |
| BlackRock, Inc. | 2.5M | $58M | 5.43% | +6.6% |
| Octagon Capital Advisors LP | 2.0M | $45M | 4.23% | +0.0% |
| NOVO HOLDINGS A/S | 1.9M | $45M | 4.17% | +0.0% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-11 | −$0.96 | — | — | — |
| 2025-09-30 | 2025-11-10 | −$0.83 | — | — | — |
| 2025-06-30 | 2025-08-11 | −$0.90 | — | — | — |
| 2025-03-31 | 2025-05-12 | −$1.90 | — | — | — |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-10 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
